fbpx

Novel Treatment Option

Injectables for Hair Loss

R

Intradermal application delivers drugs directly to the hair follicles.

R

Positive results for both women and men.

R

Lower risk of long-term systemic side effects, given low treatment frequency.

R

Injected drugs have proven clinical benefit for pattern hair loss.

R

Clinically beneficial even in patients who did not sufficiently respond to topical and/or oral modalities.

R

Effective in preventing hair loss and promoting new hair growth.

Real Results

Dutasteride 0.1%

Sterile Solution for Intradermal Injection

Assessed at 12 month time-point, after a total of four treatments (every 3 months)

Minoxidil 0.75%

Sterile Solution for Intradermal Injection

Assessed six weeks after a 10-week treatment block

Clinical Trials

i

Mesotherapy with Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice

i

Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial

i

Mesotherapy with Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice

Ready to Get Started?

Fill out our provider enrollment form and a member of our team will reach out to discuss next steps and answer any questions.

Questions?

Please use the form below and we’ll reach out within 24 hours

9 + 2 =